{"id":"F2020L00212","name":"Statement of Principles concerning acute pancreatitis (Balance of Probabilities) (No. 6 of 2020)","slug":"statement-of-principles-concerning-acute-pancreatitis-balance-of-probabilities-no-6-of-2020","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"in_force","isInForce":true,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":440399,"registerId":"F2020L00212-fast-fetch-1775956040029","compilationNumber":null,"startDate":"2026-04-12","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Statement of Principles concerning acute pancreatitis (Balance of Probabilities) (No. 6 of 2020)","content":"---\nmeta-content-style-type: text/css\nmeta-content-type: application/xhtml+xml; charset=utf-8\nmeta-generator: Aspose.Words for .NET 20.2\n---\n\n?xml version=\"1.0\" encoding=\"utf-8\" standalone=\"no\"?>\n\n\n\n \n\nStatement of Principles\n\nconcerning\n\nACUTE PANCREATITIS (Balance of Probabilities)\n\n(No. 6 of 2020)\n\nThe Repatriation Medical Authority determines the following Statement of Principles under subsection 196B(3) of the Veterans' Entitlements Act 1986.\n\n \n\nDated 28 February 2020\n\n \n\n \n\n \n\n \n\n \n\n| The Common Seal of the Repatriation Medical Authority was affixed to this instrument at the direction of:
|\n| --- |\n| 
Professor Nicholas Saunders AO
Chairperson
|\n\n\n \n\n \n\n\nContents\n\n1 Name\n\n2 Commencement\n\n3 Authority\n\n4 Repeal\n\n5 Application\n\n6 Definitions\n\n7 Kind of injury, disease or death to which this Statement of Principles relates\n\n8 Basis for determining the factors\n\n9 Factors that must exist\n\n10 Relationship to service\n\n11 Factors referring to an injury or disease covered by another Statement of Principles\n\nSchedule 1 - Dictionary\n\n1 Definitions\n\n \n\n\n\n\n1 Name\n\nThis is the Statement of Principles concerning acute pancreatitis (Balance of Probabilities) (No. 6 of 2020).\n\n2 Commencement\n\n This instrument commences on 23 March 2020.\n\n3 Authority\n\nThis instrument is made under subsection 196B(3) of the Veterans' Entitlements Act 1986.\n\n4 Repeal\n\nThe Statement of Principles concerning acute pancreatitis No. 86 of 2011 (Federal Register of Legislation No. F2011L01444) made under subsection 196B(3) of the VEA is repealed.\n\n5 Application\n\nThis instrument applies to a claim to which section 120B of the VEA or section 339 of the Military Rehabilitation and Compensation Act 2004 applies.\n\n6 Definitions\n\nThe terms defined in the Schedule 1 - Dictionary have the meaning given when used in this instrument.\n\n7 Kind of injury, disease or death to which this Statement of Principles relates\n\n(1) This Statement of Principles is about acute pancreatitis and death from acute pancreatitis.\n\nMeaning of acute pancreatitis\n\n(2) For the purposes of this Statement of Principles, acute pancreatitis means an acute inflammatory condition due to auto-digestion of pancreatic tissue by its own enzymes.\n\nNote: Acute pancreatitis typically presents with abdominal pain. It is usually associated with raised levels of pancreatic enzymes in blood or urine.\n\n(3) While acute pancreatitis attracts ICD‑10‑AM code K85, in applying this Statement of Principles the meaning of acute pancreatitis is that given in subsection (2).\n\n(4) For subsection (3), a reference to an ICD-10-AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM), Tenth Edition, effective date of 1 July 2017, copyrighted by the Independent Hospital Pricing Authority, ISBN 978-1-76007-296-4.\n\nDeath from acute pancreatitis\n\n(5) For the purposes of this Statement of Principles, acute pancreatitis, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's acute pancreatitis.\n\nNote: terminal event is defined in the Schedule 1 – Dictionary.\n\n8 Basis for determining the factors\n\nOn the sound medical‑scientific evidence available, the Repatriation Medical Authority is of the view that it is more probable than not that acute pancreatitis and death from acute pancreatitis can be related to relevant service rendered by veterans or members of the Forces under the VEA, or members under the MRCA.\n\nNote: MRCA, relevant service and VEA are defined in the Schedule 1 – Dictionary.\n\n9 Factors that must exist\n\nAt least one of the following factors must exist before it can be said that, on the balance of probabilities, acute pancreatitis or death from acute pancreatitis is connected with the circumstances of a person's relevant service:\n\n(1) smoking at least 15 pack-years of cigarettes, or the equivalent thereof in other tobacco products, before the clinical onset of acute pancreatitis, and where smoking has ceased, the clinical onset of acute pancreatitis has occurred within ten years of cessation;\n\nNote: pack-years of cigarettes, or the equivalent thereof in other tobacco products is defined in the Schedule 1 - Dictionary. \n\n(2) consuming an average of at least 420 grams of alcohol per week for at least the ten years before the clinical onset of acute pancreatitis;\n\nNote: Alcohol consumption is calculated utilising the Australian Standard of ten grams of alcohol per standard alcoholic drink.\n\n(3) having cholelithiasis at the time of the clinical onset of acute pancreatitis;\n\n(4) having biliary microlithiasis or biliary sludge at the time of the clinical onset of acute pancreatitis;\n\nNote: biliary microlithiasis or biliary sludge is defined in the Schedule 1 - Dictionary. \n\n(5) having pancreatic outflow obstruction due to a disorder from the specified list at the time of the clinical onset of acute pancreatitis;\n\nNote: pancreatic outflow obstruction is defined in the Schedule 1 - Dictionary. \n\n(6) having penetrating or major blunt trauma to the upper abdomen or to the back, within the seven days before the clinical onset of acute pancreatitis;\n\n(7) having a spinal cord injury within the seven days before the clinical onset of acute pancreatitis;\n\n(8) undergoing a procedure from the specified list of procedures, within the 30 days before the clinical onset of acute pancreatitis;\n\nNote: specified list of procedures is defined in the Schedule 1 - Dictionary.\n\n(9) undergoing endoscopic retrograde cholangio-pancreatography, endoscopic sphincterotomy of the sphincter of Oddi, or manometry of the sphincter of Oddi within the seven days before the clinical onset of acute pancreatitis;\n\n(10) undergoing a course of peritoneal dialysis or haemodialysis for renal disease at the time of the clinical onset of acute pancreatitis;\n\n(11) having a solid organ transplant before the clinical onset of acute pancreatitis;\n\n(12) being treated with a drug or a drug from a class of drugs from the specified list of drugs, at the time of the clinical onset of acute pancreatitis;\n\nNote: specified list of drugs is defined in the Schedule 1 - Dictionary. \n\n(13) being treated with a drug which is associated in the individual with:\n\n(a) the development of the symptoms or signs of acute pancreatitis within 30 days of commencing drug therapy; and\n\n(b) the cessation of the symptoms or signs of acute pancreatitis following the discontinuation of drug therapy; and\n\n(c) an absence of clinical or laboratory evidence of acute pancreatitis prior to beginning drug therapy; and\n\n(d) where treatment with the drug continued for at least the three days before the clinical onset of acute pancreatitis;\n\n(14) having diabetes mellitus at the time of the clinical onset of acute pancreatitis;\n\n(15) having hypertriglyceridaemia resulting in triglyceride levels above 11.3 millimoles per litre (or 1 000 milligrams per decilitre) at the time of the clinical onset of acute pancreatitis;\n\n(16) having hypercalcaemia at the time of the clinical onset of acute pancreatitis;\n\n(17) having a disease from the specified list of diseases at the time of the clinical onset of acute pancreatitis;\n\nNote: specified list of diseases is defined in the Schedule 1 - Dictionary. \n\n(18) having a disorder resulting in disseminated intravascular coagulation and/or profound systemic hypotension with pancreatic acinar damage within the seven days before the clinical onset of acute pancreatitis;\n\n(19) having an acute infection with an organism at the time of the clinical onset of acute pancreatitis;\n\nNote: acute infection with an organism is defined in the Schedule 1 - Dictionary. \n\n(20) having infection with human immunodeficiency virus at the time of the clinical onset of acute pancreatitis;\n\n(21) having an infestation from the specified list of infestations at the time of the clinical onset of acute pancreatitis;\n\nNote: specified list of infestations is defined in the Schedule 1 - Dictionary. \n\n(22) being envenomated by a snake or scorpion from the specified list within the seven days before the clinical onset of acute pancreatitis;\n\nNote: snake or scorpion from the specified list is defined in the Schedule 1 - Dictionary. \n\n(23) having acute toxicity after oral ingestion of mushrooms containing alpha-amanitin within the seven days before the clinical onset of acute pancreatitis;\n\nNote: alpha-amanitin is defined in the Schedule 1 - Dictionary.\n\n(24) ingesting an agent from the specified list of agents and experiencing acute toxicity within the seven days before the clinical onset of acute pancreatitis;\n\nNote: specified list of agents is defined in the Schedule 1 - Dictionary.\n\n(25) for severe acute pancreatitis only, being obese at the time of the clinical onset of severe acute pancreatitis;\n\nNote: being obese and severe acute pancreatitis are defined in the Schedule 1 - Dictionary.\n\n(26) inability to obtain appropriate clinical management for acute pancreatitis.\n\n10 Relationship to service\n\n(1) The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person.\n\n(2) The factor set out in subsection 9(26) applies only to material contribution to, or aggravation of, acute pancreatitis where the person's acute pancreatitis was suffered or contracted before or during (but did not arise out of) the person's relevant service.\n\n11 Factors referring to an injury or disease covered by another Statement of Principles\n\nIn this Statement of Principles:\n\n(1) if a factor referred to in section 9 applies in relation to a person; and\n\n(2) that factor refers to an injury or disease in respect of which a Statement of Principles has been determined under subsection 196B(3) of the VEA;\n\nthen the factors in that Statement of Principles apply in accordance with the terms of that Statement of Principles as in force from time to time.\n\n \n\n \n\nSchedule 1 - Dictionary \n\nNote: See Section 6\n\n1 Definitions\n\nIn this instrument:\n\n acute infection with an organism means serological and/or clinical evidence of acute infection with one of the following organisms:\n\n(a) coxsackievirus;\n\n(b) Cryptosporidium;\n\n(c) cytomegalovirus;\n\n(d) Epstein-Barr virus;\n\n(e) hepatitis virus;\n\n(f) herpes simplex virus;\n\n(g) Legionella spp;\n\n(h) Leptospira spp;\n\n(i) measles virus;\n\n(j) mumps virus;\n\n(k) Mycobacterium avium;\n\n(l) Mycobacterium tuberculosis;\n\n(m) Mycoplasma pneumoniae;\n\n(n) Orientia tsutsugamushi;\n\n(o) Salmonella enterica;\n\n(p) Salmonella bongori; or\n\n(q) varicella-zoster virus.\n\n acute pancreatitis—see subsection 7(2).\n\n alpha-amanitin means the cyclopeptide toxin present in some mushrooms such as Amanita phalloides which produces amanita poisoning.\n\n being obese means having a Body Mass Index (BMI) of 30 or greater.\n\nNote: BMI is also defined in the Schedule 1 - Dictionary.\n\n biliary microlithiasis or biliary sludge means the presence of small stones (1-2 millimetres) due to aggregation of bile constituents into a stone or calculus, or a collection of crystals, glycoproteins, protein, cellular debris and mucin in the biliary tract.\n\n BMI means W/H2 where:\n\nW is the person's weight in kilograms; and\n\nH is the person's height in metres.\n\n MRCA means the Military Rehabilitation and Compensation Act 2004.\n\n pack-years of cigarettes, or the equivalent thereof in other tobacco products means a calculation of consumption where one pack-year of cigarettes equals twenty tailor-made cigarettes per day for a period of one calendar year, or 7 300 cigarettes. One tailor-made cigarette approximates one gram of tobacco or one gram of cigar or pipe tobacco by weight. One pack-year of tailor-made cigarettes equates to 7.3 kilograms of smoking tobacco by weight. Tobacco products mean cigarettes, pipe tobacco or cigars, smoked alone or in any combination.\n\n pancreatic outflow obstruction means a demonstrated obstruction to the pancreatic ductal system, and which may be caused by one of the following disorders:\n\n(a) ampullary, duodenal or pancreatic tumours (primary and secondary tumours);\n\n(b) choledococoele;\n\n(c) foreign body; or\n\n(d) periampullary duodenal diverticula.\n\nNote: A foreign body may include, but is not limited to, a migrating stent or tube, or a bezoar.\n\n relevant service means:\n\n(a) eligible war service (other than operational service) under the VEA;\n\n(b) defence service (other than hazardous service and British nuclear test defence service) under the VEA; or\n\n(c) peacetime service under the MRCA.\n\nNote: MRCA and VEA are also defined in the Schedule 1 - Dictionary.\n\n severe acute pancreatitis means acute pancreatitis requiring hospitalisation; or death from acute pancreatitis.\n\n snake or scorpion from the specified list means:\n\n(a) Cerastes cerastes;\n\n(b) Tityus asthenes;\n\n(c) Tityus trinitatis; or\n\n(d) Viperidae family.\n\n specified list of agents means:\n\n(a) aspirin in overdose;\n\n(b) carbamate insecticide;\n\n(c) methyl alcohol;\n\n(d) organophosphorous insecticide; or\n\n(e) paracetamol in overdose.\n\n specified list of diseases means:\n\n(a) Henoch-Schönlein purpura;\n\n(b) inflammatory bowel disease;\n\n(c) microangiopathic haemolytic anaemia;\n\n(d) microscopic polyangiitis;\n\n(e) polyarteritis nodosa; or\n\n(f) systemic lupus erythematosus.\n\n specified list of drugs means:\n\n(a) ACE inhibitors;\n\n(b) analgesics and opioids;\n\n(c) angiotensin receptor blockers;\n\n(d) anti-arrhythmics;\n\n(e) antibacterials;\n\n(f) anticonvulsants;\n\n(g) antipsychotics;\n\n(h) antithyroid agents;\n\n(i) antituberculars;\n\n(j) antivirals;\n\n(k) cancer chemotherapy agents;\n\n(l) cancer immunotherapy agents;\n\n(m) cannabis;\n\n(n) centrally acting adrenergics;\n\n(o) cholesterol lowering drugs;\n\n(p) diuretics (loop, thiazide);\n\n(q) estrogens;\n\n(r) glucocorticoids (systemic);\n\n(s) H2 antagonists,\n\n(t) incretins (dipeptidyl peptidase-4 inhibitors);\n\n(u) inflammatory bowel disease agents;\n\n(v) intravenous lipid emulsion;\n\n(w) propofol;\n\n(x) proton pump inhibitors;\n\n(y) pyridoxine; or\n\n(z) retinoids.\n\n specified list of infestations means:\n\n(a) ascariasis;\n\n(b) clonorchiasis;\n\n(c) Echinococcus granulosus;\n\n(d) Ancylostoma duodenale or Necator americanus; or\n\n(e) strongyloidiasis.\n\n specified list of procedures means:\n\n(a) intra-abdominal surgery;\n\n(b) intrathoracic surgery;\n\n(c) spinal surgery; or\n\n(d) upper gastrointestinal endoscopy.\n\n terminal event means the proximate or ultimate cause of death and includes the following:\n\n(a) pneumonia;\n\n(b) respiratory failure;\n\n(c) cardiac arrest;\n\n(d) circulatory failure; or\n\n(e) cessation of brain function.\n\n VEA means the Veterans' Entitlements Act 1986.\n\n \n\n \n","sortOrder":0}],"analysis":{"flash_summary_failed":{"failed":true,"reason":"A positive credit balance is required for all requests, including BYOK, so fallback providers remain available. Add credits at https://vercel.com/d?to=%2F%5Bteam%5D%2F%7E%2Fai%3Fmodal%3Dtop-up to continue.","source":"analysis-cron"},"kimi_summary":{"content_quality":"ok","complexity_score":5,"scope_assessment":{"changed":false,"description":"The legislation maintains its original purpose as a medical-determination instrument for a specific condition (acute pancreatitis) under the veterans' compensation scheme. While it updates and expands the specific causal factors from its 2011 predecessor (adding factors like obesity for severe cases and refining drug-related criteria), it has not expanded beyond its core function of establishing service-connection criteria for this single medical condition."},"complexity_factors":["26 distinct causal factors in Section 9, many with nested conditions (e.g., factor 9(1) requires both smoking quantity AND timing relative to cessation)","Multiple defined terms requiring cross-reference to Schedule 1 (approximately 20 defined terms including technical medical terms like 'biliary microlithiasis' and 'pancreatic outflow obstruction')","Extensive use of 'specified lists' that must be looked up in the Dictionary (6 separate lists covering drugs, diseases, procedures, organisms, infestations, and agents)","Temporal conditions attached to factors (e.g., 'within 7 days', 'within 30 days', 'within 10 years', 'for at least 10 years')","Factor 9(13) contains a 4-part conjunctive test for drug-induced pancreatitis requiring all elements to be satisfied","Section 11 creates interdependence with other Statements of Principles — requires knowledge of external instruments","Dual statutory framework application (VEA and MRCA) with different service definitions","Medical and scientific terminology throughout (ICD-10-AM codes, specific organisms, drug classes, anatomical references)"],"plain_english_summary":"This Statement of Principles from the Repatriation Medical Authority sets the medical rules for deciding whether a veteran’s acute pancreatitis is linked to Australian military service, affecting entitlement to compensation and treatment. It applies to ADF members, decision-makers at the Department of Veterans’ Affairs, and clinicians who provide evidence for claims.\n\nIt lists specific risk factors so that if at least one is service-related and the condition arose on the balance of probabilities, the disease can be accepted as service-related."},"flash_summary":{"complexity_score":6,"scope_assessment":{"changed":false,"description":"This instrument repeals and replaces the earlier 2011 Statement of Principles for acute pancreatitis (s 4) but remains within the same statutory purpose: setting medical factors for linking acute pancreatitis (and death from it) to relevant service for compensation decisions (ss 3–5, 7–9). The replacement updates and clarifies factors, thresholds and definitions (Schedule 1) but does not expand the instrument beyond its original functional scope of providing adjudicative criteria for service connection."},"complexity_factors":["Multiple lists of specified items in Schedule 1 (organisms, drugs, diseases, infestations, agents, procedures, snakes) — increases cross‑checking obligations","About two dozen distinct causal factors in s 9, several with their own sub‑conditions and timing windows","Nested conditional logic — e.g. s 9(13) requires four concurrent subconditions to establish a drug‑caused case","Several time‑limited windows (7 days, 30 days, 10 years) and threshold values (420 g alcohol/week, >11.3 mmol/L triglycerides, BMI ≥30) that require quantitative proof","Cross‑references to other Statements of Principles where an identified factor overlaps another SOP (s 11) — introduces external dependencies","Defined technical terms in Schedule 1 (pack‑years, pancreatic outflow obstruction, biliary microlithiasis, alpha‑amanitin) require medical interpretation","Repeal and replacement of a prior SOP (s 4) means assessors must be aware of changes relative to the earlier instrument","Application depends on different statutes (VEA and MRCA) with differing concepts of \"relevant service\" (s 5, Schedule 1), adding legal context to the medical rules"],"plain_english_summary":"**What this instrument does (mechanics)\n\n- Replaces an earlier Statement of Principles about acute pancreatitis and sets the medical criteria that will be used to decide whether a veteran's acute pancreatitis (or death from it) is connected to their military service for the purposes of veterans' compensation law (see sections 3–5 and 7). It applies to claims under the Veterans' Entitlements Act and the Military Rehabilitation and Compensation Act (s 5).\n\n- Defines \"acute pancreatitis\" for claims (s 7(2)) and lists specific medical and exposure-related factors. If at least one of those factors is present and is related to the person's relevant service, then, on the balance of probabilities, the condition is taken to be connected with service (ss 8–9, 10). The listed factors include smoking and alcohol thresholds, gallstones and biliary sludge, certain traumas and procedures within short time windows, some infections, certain drugs and drug‑reaction patterns, metabolic abnormalities (very high triglycerides, hypercalcaemia), diabetes, organ transplant, dialysis, certain infestations and envenomations, ingestion of particular toxins or overdoses, and inability to obtain appropriate clinical management (see s 9 and Schedule 1 definitions).\n\n- Provides precise definitions and thresholds used in assessing claims: for example, smoking defined in pack‑years, alcohol consumption given as 420 grams of alcohol per week for 10 years, obesity as BMI ≥ 30, hypertriglyceridaemia threshold > 11.3 mmol/L, and time windows for trauma/procedures (Schedule 1 and s 9).\n\n- Limits how one factor is treated if it refers to another disease already covered by a different Statement of Principles: where that happens, the other Statement of Principles governs (s 11).\n\n\nWho this affects\n\n- Veterans, current or former members of the Australian Defence Force, and claimants who seek compensation or pension under the relevant parts of the VEA or MRCA for acute pancreatitis or death from it (s 5, Schedule 1 definitions of \"relevant service\").\n\n- Departmental decision makers and medical assessors who apply this Statement of Principles when deciding service connection for claims (ss 8–11).\n\n\nWhy it matters (official purpose and practical effect)\n\n- Officially, the Repatriation Medical Authority states that, based on available medical evidence, it is more probable than not that acute pancreatitis can be related to relevant service (s 8). Practically, the instrument sets the medical/causal rules that turn clinical and exposure facts into a legal finding of service connection for compensation decisions.\n\n\nPractical implications, incentives and costs (concise analysis)\n\n- Who pays: if a claimant meets the rules and a decision maker grants service connection, the government (through the Department administering the VEA/MRCA) becomes liable for whatever entitlements attach to that finding (implicit from the application in s 5 and the operation of the VEA/MRCA).\n\n- What claimants must supply: medical evidence of the diagnosed acute pancreatitis, documentation or clinical/laboratory proof of the listed factors (e.g. triglyceride or calcium levels, records of procedures, drug histories, records of smoking or alcohol consumption), and evidence tying those factors to the person's relevant service (ss 7–10, Schedule 1). Some factors have tight timing windows (e.g. trauma within 7 days, certain procedures within 7–30 days) which concentrates evidentiary requirements on recent clinical records (s 9(6)–(9)).\n\n- Administrative burden and measurement issues: thresholds and timing windows create clear rules but also generate practical difficulties — e.g. reliably proving \"420 grams of alcohol per week for 10 years\" or \"15 pack‑years\" often relies on self‑report or incomplete records; some definitions (pack‑year calculation, BMI formula, lists of specified drugs/agents) are technical and will require medical or forensic interpretation (Schedule 1).\n\n- Bureaucratic discretion and cross‑references: the RMA sets the Statement of Principles but decision makers must still evaluate the evidence and the link to relevant service. Where a listed factor points to another disease covered by a different Statement of Principles, that other document governs the linkage, which can introduce cross‑instrument complexity (s 11).\n\n- Effects on behaviour and markets: the instrument is a rule for adjudication of claims. It does not itself regulate private businesses or clinical practice, though the inclusion of many drug classes and procedures as recognised factors may affect how clinical histories are documented during service and how claims related to prescribed medicines are assessed.\n\n- Concentrated benefits and diffuse costs: benefits (successful claims) will be concentrated among claimants who can show one of the listed factors related to service. Costs (award of entitlements) fall on the government and are diffuse across taxpayers.\n\n\nImportant implementation details to note\n\n- Several factors have short temporal windows (7 or 30 days) between exposure/procedure and clinical onset (s 9(6)–(9), Schedule 1 definitions). Proof must usually show both the exposure and the timing.\n\n- One factor (9(13)) sets a four‑part test for drug‑caused pancreatitis (onset within 30 days, cessation resolves symptoms, no prior evidence before drug, drug used for at least 3 days); that is more nuanced than a simple exposure list.\n\n- Factor 9(26) (\"inability to obtain appropriate clinical management\") applies only where acute pancreatitis existed before or during service (but did not arise out of service) and can only be used to show material contribution or aggravation (s 10(2)).\n\n\nSource citations: key operative clauses are sections 5–11 and the Schedule 1 dictionary entries, which set thresholds, time windows, and the lists of organisms, drugs, procedures and other specified agents.\n"}},"importantCases":[],"_links":{"self":"/api/acts/statement-of-principles-concerning-acute-pancreatitis-balance-of-probabilities-no-6-of-2020","history":"/api/acts/statement-of-principles-concerning-acute-pancreatitis-balance-of-probabilities-no-6-of-2020/history","analysis":"/api/acts/statement-of-principles-concerning-acute-pancreatitis-balance-of-probabilities-no-6-of-2020/analysis","conflicts":"/api/acts/statement-of-principles-concerning-acute-pancreatitis-balance-of-probabilities-no-6-of-2020/conflicts","importantCases":"/api/acts/statement-of-principles-concerning-acute-pancreatitis-balance-of-probabilities-no-6-of-2020/important-cases","documents":"/api/acts/statement-of-principles-concerning-acute-pancreatitis-balance-of-probabilities-no-6-of-2020/documents"}}